RNA uridyl transferases TUT4/7 differentially regulate miRNA variants depending on the cancer cell type.
View / Open Files
Authors
Medhi, Ragini
Price, Jonathan
Furlan, Giulia
Gorges, Beronia
Sapetschnig, Alexandra
Publication Date
2022-03Journal Title
RNA
ISSN
1355-8382
Publisher
Cold Spring Harbor Laboratory
Pages
rna.078976.121-rna.078976.121
Type
Article
This Version
VoR
Physical Medium
Print-Electronic
Metadata
Show full item recordCitation
Medhi, R., Price, J., Furlan, G., Gorges, B., Sapetschnig, A., & Miska, E. A. (2022). RNA uridyl transferases TUT4/7 differentially regulate miRNA variants depending on the cancer cell type.. RNA, rna.078976.121-rna.078976.121. https://doi.org/10.1261/rna.078976.121
Abstract
The human terminal uridyl transferases TUT4 and TUT7 (TUT4/7) catalyze the additions of uridines at the 3' end of RNAs, including the precursors of the tumor suppressor miRNA let-7 upon recruitment by the oncoprotein LIN28A. As a consequence, let-7 family miRNAs are down-regulated. Disruption of this TUT4/7 activity inhibits tumorigenesis. Hence, targeting TUT4/7 could be a potential anticancer therapy. In this study, we investigate TUT4/7-mediated RNA regulation in two cancer cell lines by establishing catalytic knockout models. Upon TUT4/7 mutation, we observe a significant reduction in miRNA uridylation, which results in defects in cancer cell properties such as cell proliferation and migration. With the loss of TUT4/7-mediated miRNA uridylation, the uridylated miRNA variants are replaced by adenylated isomiRs. Changes in miRNA modification profiles are accompanied by deregulation of expression levels in specific cases. Unlike let-7s, most miRNAs do not depend on LIN28A for TUT4/7-mediated regulation. Additionally, we identify TUT4/7-regulated cell-type-specific miRNA clusters and deregulation in their corresponding mRNA targets. Expression levels of miR-200c-3p and miR-141-3p are regulated by TUT4/7 in a cancer cell-type-specific manner. Subsequently, BCL2, which is a well-established target of miR-200c is up-regulated. Therefore, TUT4/7 loss causes deregulation of miRNA-mRNA networks in a cell-type-specific manner. Understanding of the underlying biology of such cell-type-specific deregulation will be an important aspect of targeting TUT4/7 for potential cancer therapies.
Keywords
LIN28A, TUT4/7, cancer, isomiRs, let-7, miRNA–mRNA, Cell Line, Tumor, DNA-Binding Proteins, Gene Expression Regulation, Neoplastic, HEK293 Cells, Humans, MicroRNAs, Neoplasms, RNA Nucleotidyltransferases, RNA Processing, Post-Transcriptional
Sponsorship
Wellcome Trust (219475/Z/19/Z)
Cancer Research UK (A27826)
Wellcome Trust (203144/Z/16/Z)
Cancer Research UK (C6946/A24843)
Wellcome Trust (092096/Z/10/Z)
Cancer Research Uk (None)
Cancer Research UK (18583)
Identifiers
External DOI: https://doi.org/10.1261/rna.078976.121
This record's URL: https://www.repository.cam.ac.uk/handle/1810/332865
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: support@repository.cam.ac.uk